PTO Rejects Claims On Stem Cell Patents
Claims on three patents covering human embryonic stem calls have been rejected by the U.S. Patent and Trademark Office following challenges by consumer advocates that said the patents stymied scientific progress...To view the full article, register now.
Already a subscriber? Click here to view full article